YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
3 Cash-Producing Stocks with Questionable Fundamentals While strong cash flow is a key indicator of stability, it doesn't always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand,…
U.S. Physical Therapy has delivered mixed results for long term holders, with the share price down 21.3% over 5 years despite a recent uptick. This puts fresh focus on whether the current US$82.47 level lines up with the cash the business…
Q2 Earnings Roundup: Encompass Health (NYSE:EHC) And The Rest Of The Outpatient & Specialty Care Segment As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2.…
LifeStance Health Group (NASDAQ:LFST): Strongest Q2 Results from the Outpatient & Specialty Care Group Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at LifeStan…
On August 14, US Physical Therapy (NYSE:USPH) announced that Nchacha Etta will become the company's Executive Vice President and Chief Financial Officer, effective September 1. The move closes out a search that began after Jason Curtis ste…
Key Points Interested in U.S. Physical Therapy, Inc.? Here are five stocks we like better. Hospital alliances are a key growth strategy: U.S. Physical Therapy's 10-year NYU Langone partnership has expanded its New York network to 60 locati…
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Tod…
Outpatient & Specialty Care Stocks Q2 Teardown: U.S. Physical Therapy (NYSE:USPH) Vs The Rest Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at U.S. Physical The…
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) Wrapping up Q2 earnings, we look at the numbers and key takeaways for the outpatient & specialty care stocks, including Surgery Partners (NASDAQ:SGRY) and its…
HOUSTON, August 14, 2026--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("I…
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 10:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Christopher ReadingPresident and Chief Operating Officer, East - Eric WilliamsInterim Chief Financial Offi…
1 Russell 2000 Stock Worth Investigating and 2 We Brush Off The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often…
Key Points Interested in U.S. Physical Therapy, Inc.? Here are five stocks we like better. Revenue and patient volumes increased: Second-quarter revenue rose 8.5% to $214 million, driven by higher visits, improved reimbursement rates and g…
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 In…
3 Healthcare Stocks We Find Risky Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have ret…
Outpatient & Specialty Care Stocks Q1 Results: Benchmarking Encompass Health (NYSE:EHC) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's…
Spotting Winners: LifeStance Health Group (NASDAQ:LFST) And Outpatient & Specialty Care Stocks In Q1 Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at LifeStance…
Option Care (OPCH) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items. T…
1 Profitable Stock Worth Your Attention and 2 We Avoid Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive tom…
U.S. Physical Therapy, Inc. (NYSE:USPH) is one of the best medical care facilities stocks to buy according to analysts. Analysts see about 29.5% average upside, and the company also has one of the cleaner facility-style profiles in the gro…
Astrana Health, Inc. ASTH shares soared 7.3% in the last trading session to close at $49.81. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 25.7% gain over the…
Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks Looking back on outpatient & specialty care stocks' Q1 earnings, we examine this quarter's best and worst performers, includin…
3 of Wall Street's Favorite Stocks with Questionable Fundamentals The stocks in this article have caught Wall Street's attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a…
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to…
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the outpatient & specialty care industry, including agilon health (NYSE:AGL) and its peers. The outpatient and specialty care industry delivers tar…
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at outpatient & specialty care stocks, starting with DaVita (NYSE:DVA). The outpati…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. U.S. Physical Therapy’s fair value estimate has been reset from about US$106.83 to roughly US$93.67, marking a clear step do…
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Select Medical (NYSE:SEM) and its peers. The outpatient and specialty care industry delivers targeted medical s…
U.S. Physical Therapy currently trades at $65.04 per share and has shown little upside over the past six months, posting a small loss of 4.3%. The stock also fell short of the S&P 500’s 11.6% gain during that period. Is there a buying oppo…
Check out the companies making headlines yesterday: Helios (NYSE:HLIO): Motion control and electronic systems manufacturer Helios Technologies (NYSE:HLIO) rose by 12.5% on Tuesday after the company reported first-quarter 2026 results that…
PACS Group Inc. (NYSE:PACS) is one of the best up and coming stocks with highest upside potential. On April 27, PACS Group appointed Carey P. Hendrickson as its Chief Financial Officer. Hendrickson, a seasoned financial leader with nearly…
Is USPH a good stock to buy? We came across a bullish thesis on U.S. Physical Therapy, Inc. on Quality At A Fair Price’s Substack. In this article, we will summarize the bulls’ thesis on USPH. U.S. Physical Therapy, Inc.'s share was tradin…
Carey P. Hendrickson, PACS Group's newly appointed Chief Financial Officer SALT LAKE CITY, April 27, 2026--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation’s largest and fastest-growing post-acute healthcare platforms, tod…
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Luckily for you, we built StockStory to…
Quest Diagnostics (DGX) came out with quarterly earnings of $2.5 per share, beating the Zacks Consensus Estimate of $2.37 per share. This compares to earnings of $2.21 per share a year ago. These figures are adjusted for non-recurring item…
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about com…